Dublin, May 15, 2024 (GLOBE NEWSWIRE) -- The "Mass Spectrometry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's offering.
The global mass spectrometry market is projected to reach $7.62 billion by 2028, registering a CAGR of 7.1%. Underpinning this growth is the rising demand for advanced analytical tools in drug development, clinical diagnostics, and environmental analysis, along with progress in proteomics and metabolomics research. Technological advancements in high-resolution instruments and the integration of mass spectrometry with other techniques are further enhancing market expansion, meeting the need for precise and efficient analysis.
Mass spectrometry has cemented its role as an essential tool in pharmaceutical research, assisting drug discovery and ensuring quality control during development to meet rigorous regulatory standards. Its application in clinical diagnostics is growing, with mass spectrometry being integral in the detection and management of diseases through biomarker assessment and therapeutic monitoring. These aspects significantly contribute to the market's growth trajectory and underscore the technique's importance in advancing public health.
Challenges to Market Adoption: Costs and Complexity
While the market outlook for mass spectrometry is positive, certain challenges such as high initial costs and the technical complexity of operations present hurdles to broader adoption. These factors can hinder potential users, especially within smaller organizations and emerging sectors, from leveraging the full capabilities of mass spectrometry technologies.
Emerging Trends: Proteomics, Metabolomics, and Food Safety Analysis
The rise of proteomics and metabolomics research demands sophisticated, high-performance mass spectrometers for intricate molecular analyses. Additionally, the food and beverage industry increasingly relies on mass spectrometry for quality assurance and regulatory compliance, further driving market demand.
Regional Domain Dominance and Segmentation Insights
With its advanced healthcare infrastructure and prominent pharmaceutical sector, North America holds the largest share of the global mass spectrometry market. The market is segmented further into products, technology, applications, and regional categories, offering nuanced insights into various market perspectives and outlining a comprehensive market landscape.
Competitive Landscape
The global mass spectrometry market is supported by a competitive environment where major companies are making significant strides in technology and product offerings. These innovations promise to enhance the utility and reach of mass spectrometry in multiple industry sectors worldwide.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 189 |
| Forecast Period | 2022-2028 |
| Estimated Market Value (USD) in 2022 | $5.07 Billion |
| Forecasted Market Value (USD) by 2028 | $7.62 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Danaher Corporation
- Waters Corporation
- BrU.K.er Corporation
- Shimadzu Corporation
- PerkinElmer, Inc.
- Rigaku Corporation
- LECO Corporation
- JEOL Ltd
For more information about this report visit https://www.researchandmarkets.com/r/26dsus
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
